Our study for the first time demonstrates that the cardioprotective effect of kirenol in GK rats is independent of lowering HG and hyperinsulinemia and altering lipid profiles and occurs probably by regulating the NF‐κB, MAPK and TGF‐β/Smad signal pathways. The gene discussed is NFKB1; the disease is Hyperinsulinemia.